Press Release Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights Aug 11
Press Release Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) Aug 11